DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Erteberel
Erteberel
Erteberel (LY500307) Product Data Sheet
Supplementary Information
WHO Drug Information Vol
TE INI (19 ) United States (12 ) Patent Application Publication ( 10) Pub
Mitochondrial Estrogen Receptors Alter Mitochondrial Priming and Response to Endocrine Therapy in Breast Cancer Cells
Mitochondrial Estrogen Receptors Alter Mitochondrial Priming and Response to Endocrine Therapy in Breast Cancer Cells
In Silico Prediction of Heliannuol A, B, C, D, and E Compounds on Estrogen Receptor Β Agonists
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
China Japan United States Europe
Potency Price List
Androgen Receptor
GSK3B Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cell Properties and Is a Novel Drug Target for Triple-Negative Breast Cancer
Sex and Gender Disparities in Melanoma
Development of Subtype-Selective Oestrogen Receptor-Based Therapeutics
Supporting Information
China Japan United States Europe
Estrogen Receptor/ERR
Clicktozoomintothepdf
Top View
Potency List 2021.Xlsx
Download Product Insert (PDF)
Suffixes Used in the Selection of INN and Their Published INN May 2018
Potency Price List.Xlsx
WO 2016/192680 Al 8 December 2016 (08.12.2016) P O P C T
Potency Price List.Xlsx
LY500307 (Erteberel) Datasheet | Buy LY500307 (Erteberel) from Supplier Selleckchem.Com
Potency List 2021.Xlsx
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri